Another study, which included 563 postmenopausal patients with stage I or stage II breast cancer, examined the relationships of the cumulative probability of survival with H-score and with the percentage of tumor cell nuclei positive for ER [21]. The gene discussed is ESR1; the disease is breast carcinoma.